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Summary
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA), first reported in a British hospi-
tal in the early 1960s, has now reached global proportions. Geographic spread of one or several
MRSA clones in a city, country, and even among countries and continents has been identified by
molecular techniques. We sought to determine whether clonal spread of MRSA has occurred in
Trinidad and Tobago from all MRSA isolates collected between 2000 and 2001.
Methods: Clinical isolates of MRSA from three major hospitals in Trinidad and Tobago were
identified by standard laboratory methods and analyzed using multiplex polymerase chain
reaction (PCR) and pulsed-field gel electrophoresis (PFGE) after SmaI digestion.
Results: There was a 12.8% prevalence of MRSA in three major regional hospitals in Trinidad and
Tobago. All 60 randomly selected MRSA strains from these hospitals produced similar PFGE
banding patterns, suggesting a genetic relatedness among strains and that they belonged to a
single clonal family. All isolates were negative for the Panton—Valentine leukocidin gene ( pvl).
These strains shared a PFGE banding pattern approximately (96%) the same as a Canadian strain
called CMRSA-6 in the Canadian National Microbiology Laboratory database.
Conclusions: We conclude that only one major PFGE genotype of MRSA clone is circulating among
the three major regional hospitals in Trinidad and Tobago suggesting one of three possible
scenarios of microevolution: (1) all were from the dissemination of a single epidemic MRSA clone
prevailing in these hospitals in Trinidad and Tobago; or (2) MRSA in Trinidad and Tobago is evolving§ This study was presented in part at the 12th International Congress of the International Society for Infectious Disease in Lisbon Portugal,
June 15—19, 2006; abstract poster 57.045, p. S256.
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more slowly than in other countries; or (3) that if other MRSA clones have been present in Trinidad
and Tobago, they have not persisted.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has
become an increasing problem in healthcare units and com-
munities around the world since it was first reported among
hospitalized patients in a British hospital in the early
1960s.1,2 Several reports of outbreaks and spread in hospi-
tals, communities, nursing homes and long-term care institu-
tions have been documented.3—8 Epidemiological links of
MRSA isolates occurring in different hospitals, countries,
and regions have been demonstrated in several places.9,10
Transmission of a clone may occur through transfer of
patients or healthcare personnel between hospitals, and
the elucidation of the mechanism of geographic spread of
such clones has been greatly facilitated by molecular tech-
niques.11 Although the prevalence rate of MRSA in Trinidad
and Tobago has been reported,12 there are no molecular
epidemiology reports available. A knowledge of the mole-
cular epidemiology of MRSA is crucial for assessing and
implementing infection control measures in any healthcare
institution or country.13
This study was carried out to delineate and document
the clonal relatedness of all MRSA clinical isolates encoun-
tered at three major regional hospitals in Trinidad
and Tobago by pulsed-field gel electrophoresis (PFGE)
testing.
Materials and methods
MRSA isolates used for this study were from routine clinical
specimens submitted to the microbiology laboratories of
three major regional hospitals (from the south, San Fernando
General Hospital; from the northwest, Port of Spain General
Hospital; and from north-central, Eric Williams Medical
Sciences Complex) in Trinidad and Tobago from January
2000 to December 2001. These isolates were identified mor-
phologically and biochemically by standard laboratory pro-
cedures.14 No duplicate isolates from a single patient were
included, and there was no history of MRSA outbreak during
this period.
Isolates were identified by latex agglutination test (Sta-
phaurex Plus; Murex Diagnostics Ltd, Dartford, UK), tube
coagulase test (Becton, Dickinson & Co, Sparks, MD, USA),
and detection of DNase (DNase agar; Oxoid Ltd, Basingstoke,
Hampshire, UK). The methicillin-resistant Staphylococcus
aureus screen latex agglutination test (Denka Seiken Co.
Ltd, Tokyo, Japan) was performed according to the manu-
facturer’s instructions. Pure isolates of MRSA were stored in
brain heart infusion (BHI) broth with 20% glycerol at 70 8C
until required for further analysis. All results were validated
using American Type Culture Collection (ATCC) quality con-
trol strains: methicillin-resistant S. aureus ATCC 43300,
methicillin-sensitive S. aureus ATCC 25923, and Staphylococ-
cus epidermidis ATCC 12228.Antimicrobial agents and minimum inhibitory
concentration (MIC) testing
Susceptibility tests were performed by the standard disk
diffusion method according to the Clinical and Laboratory
Standards Institute (formerly NCCLS) guidelines.15 The follow-
ing antimicrobial agents were tested: ampicillin, amoxicillin/
clavulanic acid, ceftriaxone, ciprofloxacin, chloramphenicol,
erythromycin, gentamicin, meropenem, oxacillin, penicillin,
tetracycline, trimethoprim—sulfamethoxazole, rifampin, and
vancomycin (Oxoid Ltd, Basingstoke, Hampshire, UK). Methi-
cillin (oxacillin) MICs were determined with the E-test system
(AB Biodisk, Solna, Sweden) according to the manufacturer’s
instructions, with resistant isolates having a breakpoint of
2 mg/l.
Detection of pvl, mecA and nuc genes by
multiplex PCR
The presence or absence of pvl,mecA gene and the presence
of nuc gene were determined for all MRSA strains by multi-
plex PCR as described elsewhere.16—18
Restriction enzyme digestion and pulsed-field gel
electrophoresis (PFGE)
PFGE was used as the genotyping method in this study and
was performed as previously described with some modifica-
tions.19 The pulsed-field gel electrophoresis was performed
using a contour-clamped homogeneous electric field appa-
ratus (CHEF DRIII, Bio-Rad Hercules, CA, USA). Gel images
were captured on the Gel Doc imaging system using Quantity
One software version 4.4.1 (Bio Rad Laboratories, Hercules
CA, USA). The resulting band patterns were analyzed by
visual inspection according to previously established cri-
teria.20,21 Gel analysis was done using Bionumerics version
3.5 (Applied Maths, Austin TX, USA), and cluster analysis was
achieved using DICE and UPGMA.
Results
Of the 1912 S. aureus isolates received from the three major
hospitals, 244 (12.8%) were MRSA. Most of these MRSA iso-
lates (96.7%) were from hospitalized patients and thus repre-
sented healthcare-associated isolates; 86.9% of the isolates
were recovered from wound swab specimens.
Half (50%) of the MRSA isolates were from the San Fer-
nando General Hospital, 48% from Port of Spain General
Hospital, and 2% from EricWilliams Medical Science Complex.
The majority (62.3%) of the isolates were recovered from the
surgical facility of each hospital, while the least (1.6%) were
from the obstetrics and gynecology facility.
As previously reported, 14% of the MRSA isolates had
oxacillin MIC values of >64 mg/l, while 86% had MIC values
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Figure 1 Agarose gel electrophoresis of PCR-amplified pro-
ducts of MRSA clinical isolates from Trinidad and Tobago, 2000—
2001. Lane 1 is the ATCC 43300 (MRSA) pvl negative, mecA and
nuc positive; lane 2 is the MSSA (ATCC 25923) pvl and nuc
positive,mecA negative. Lanes 3—12 are representative of MRSA
isolates from Trinidad and Tobago, with all MRSA mecA and nuc
positive, pvl negative.
Figure 2 Sma1 PFGE profiles of MRSA isolates from threemajor
regional hospitals in Trinidad and Tobago, 2000—2001. Lanes 1—9
are representative of MRSA isolates from Trinidad and Tobago
regional hospitals; lanes 10—12 from St. Joseph’s Hospital,
Hamilton, Ontario, Canada. Lambda (l) DNA PFGE molecular
size marker is indicated in the respective lanes.>256 mg/l, and the antimicrobial susceptibility testing
revealed complete resistance to ceftriaxone, erythromycin
and gentamicin.12 All the MRSA isolates were susceptible to
vancomycin, rifampin and chloramphenicol, and no antibio-
tic resistance pattern was found to be specific to a particular
ward. Multiplex PCR analysis confirmed the presence of the
genes encoding nuclease (nuc), and mecA in all 244 MRSA
isolates and all strains were negative for pvl (Figure 1).
The clonal results of the MRSA isolates by PFGE genotyping
were striking and showed a similar banding pattern among all
the isolates from these hospitals in Trinidad and Tobago
(Figure 2). This result supports our opinion that MRSA infec-
tions in this studywerehospital-acquired, sinceover96%of the
isolates recovered were from patients who were in hospital,
and the remaining isolates (4%) came from outpatient clinics
and could equally be said to be hospital-acquired as these
patients had a past history of hospitalization.Discussion
Molecular typing results from this study demonstrate that
there was a single major PFGE genotype of MRSA clone
prevailing in the three regional hospitals in Trinidad and
Tobago. A similar finding of a single predominant MRSA clone
prevailing in various large hospitals in a country has been
documented.22 A single MRSA clone still prevailing in thecountry means that there has not been any clonal evolution
among the MRSA isolates. It is also possible that no new MRSA
clones have been recently introduced to these hospitals or if
they have been introduced, they have not persisted.
The relative genetic unity ofMRSA isolatesmaybe a result
of a single introduction of MRSA into Trinidad hospitals or an
acquisition of genetic elements such as phages, transposons,
or plasmids that integrated into the staphylococcal chromo-
some as has been reported.23 The island of Trinidad is 5128 sq
km in size with an accessible road network and continuous
movement of people and services. There is a continuous
inter-referral of patients and movement of healthcare staff
between hospitals in the country, and this could have facili-
tated the spread of a particular MRSA clone as noted else-
where.22 Reports from other areas have noted that in many
hospitals, the lack of adequate efforts to prevent MRSA
spread, lack of strict adherence to infection control pre-
cautions, and lack of an antibiotics use policy have all
contributed to the spread of MRSA clones.24,25 All these risk
factors are prevalent in thesemajor hospitals in Trinidad and
Tobago.
A comparison of the MRSA isolates from these hospitals in
Trinidad and Tobago with some strains from Canada revealed
that they were approximately (96%) the same in PFGE band-
ing pattern to a Canadian strain called CMRSA-6 in the
Canadian National Microbiology Laboratory database. This
strain was first identified in the western region of Canada in
1995 with one isolate, but has now increased to 1035 isolates
to date. It comprises five PFGE macrorestriction patterns
(CDN-type 0068, 0519, 0320, 0347, 0823) with 0068 being the
predominant strain; but it does not have any other PFGE
name related to those encountered in other countries. The
majority of the CMRSA-6 isolates have been encountered in
the western region where in 1999 most of the strains were
from a single site. Infection associated with the CMRSA-6
isolates was negligible in 1995—1997, but increased to epi-
demic proportion in 1998 through 2000; in the past five years
it has been on the decrease.
The CMRSA-6 strain, which does not have any other PFGE
type identified in any other country, is closely related to the
single clone seen in Trinidad. It is surprising to note that only
one clonal MRSA is circulating in a country that is a major
destination for tourists, visitors and returning residents from
North America and Europe in the Caribbean. Each year several
thousand people visit Trinidad. For example between January
2000 and December 2001 a total of 1 668 465 arrivals by both
sea and air of people (visitors, students, returning residents,
diplomats, in-transit passengers) to Trinidad and Tobago was
recorded.26 It is generally believed that migration and move-
ment of people from one place to another, whether it is for
tourism or other purposes, may have profound effects on the
dissemination of microorganisms into different populations.
An overall prevalence of MRSA in healthy individuals without
known risk factors has previously been documented as 0.24% in
San Francisco, 0.26% in healthy children and guardians in New
York City, and 0.06% in the large sample of a Portuguese
population.27 With such a minimal prevalence rate from
healthy individuals in the city, hospital or an area, the possi-
bility of transfer tootherscouldbe low;and thismayhavebeen
the case in Trinidad and Tobago.
The majority of the isolates were recovered from wound
swab specimens of patients predominantly in the surgical
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been noted in reports from other hospitals.28 In the present
study, none of the MRSA isolates were pvl-positive and similar
results have been obtained in isolates from France with all
healthcare-associated MRSA.29 Several publications have
strongly associated Panton—Valentine leukocidin (PVL) with
community-associated MRSA.18,30,31 The lack of pvl in our
isolates supports our conclusion that the majority of the
Trinidad and Tobago isolates are healthcare-associated MRSA
since they were not obtained from patients (nasal samples)
screened prior to their admission to hospital, community
strains or countrywide populations.
Unfortunately, there is no national or hospital policy on
the use of pre-operative prophylactic antimicrobial treat-
ment or the empirical antimicrobial treatment of surgical
site infections in these regional hospitals in Trinidad and
Tobago. However, there are plans to formulate such a policy
in one of the hospitals, and infection control nurses and an
infection control committee are being set up or revived.
Since a single clone is responsible for the MRSA in these
regional hospitals in the country, there is a need to imple-
ment effective infection prevention and control measures
that should include continuous staff education, contact iso-
lation for MRSA-positive patients, an antibiotic use policy,
and cohort nursing of MRSA-positive and exposed patients in
epidemic situations, to limit further transmission.
Conclusions
It was determined by PFGE that only one clonally relatedMRSA
is circulating among the three major regional hospitals in
Trinidad and Tobago, suggesting that: (1) all these were from
a single epidemic MRSA clone prevailing in these hospitals in
Trinidad and Tobago; or (2) MRSA in Trinidad and Tobago is
evolving more slowly than in other countries; or (3) no new
MRSA clones have been recently introduced to these hospitals
or if they have been introduced, they have not persisted. The
MRSA strains and their variants fromTrinidad and Tobagowhen
compared with Canadian PFGE types revealed that they are
genetically closely related, according to the interpretative
criteria ofTenoveret al.20 (approximately96%byRFLPbanding
pattern), to Canadian strain CMRSA-6 in the Canadian National
Microbiology Laboratory database.
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